SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair.
Xin WangChen CaoXiangyu TanXueyao LiaoXiaofang DuXueqian WangTing LiuDanni GongZheng HuXun TianPublished in: Cell & bioscience (2023)
SETD8 was a promising therapeutic target to ameliorate cisplatin resistance and improve the efficacy of chemotherapy.